This opportunity is no longer accepting applications.
grant NOT-HL-22-052

Notice of Special Interest (NOSI): Advancing Research in Lipoprotein(a) and Cardiovascular Disease (R01 Clinical Trials Allowed) and (R01 No Clinical Trials Allowed)

This grant opportunity encourages research on the role lipoprotein(a) plays in cardiovascular disease. It supports collaborative projects across various disciplines focusing on basic, preclinical, and clinical studies. The research should explore the biology and impacts of Lp(a) and work on creating new models and treatments.

This NOSI aims to encourage research on the role of lipoprotein(a) in cardiovascular disease. It supports multidisciplinary collaborations for basic, preclinical, and mechanistic clinical studies. The research should address the biology, pathophysiology, and clinical implications of Lp(a), as we…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Heart, Lung, and Blood Institute

Dates

Opportunity Released: November 10, 2022

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.